Cancer Family
Thymus Epithelial Neoplasm
CI-CAN-00000365Explore in graph →
Non-malignant39 active trials1 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000365Explore in graph →
Clinical trials
136 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07750353 | A Phase II, Investigator-Initiated Exploratory Study of Sacituzumab Tirumotecan for Previously Treated Unresectable Thymic Carcinomas(XANTHOS) | not yet recruiting | Phase 2 | 35 | National Cancer Center, JapanOTHER_GOV | 1 | Aug 6, 2026 | clinicaltrials |
| NCT07693855 | Hypofractionated Adjuvant Radiotherapy for Thymic Epithelial Tumors(THOR) | not yet recruiting | N/A | 69 | National Taiwan University HospitalOTHER | 1 |
| Jul 16, 2026 |
| clinicaltrials |
| NCT07571525 | Thymic Disease, Autoimmunity, and Neuromuscular Junction Integrity in Myasthenia Gravis(TAILOR-MG) | not yet recruiting | — | 40 | IRCCS San RaffaeleOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT07479628 | Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma | not yet recruiting | Phase 2 | 31 | Shanghai Chest HospitalOTHER | 0 | Mar 18, 2026 | clinicaltrials |
| NCT07383142 | Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2) | not yet recruiting | N/A | 202 | Shanghai Zhongshan HospitalOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT07328074 | Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis | not yet recruiting | — | 70 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07343453 | A Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan in Second-Line and Subsequent Treatments for Advanced Thymic Epithelial Tumors | not yet recruiting | Phase 2 | 38 | Sun Yat-sen UniversityOTHER | 0 | Jan 15, 2026 | clinicaltrials |
| NCT06654830 | RATT Vs. VATT for Early-stage TETs | not yet recruiting | Phase 2 | 100 | Shanghai Zhongshan HospitalOTHER | 0 | Oct 30, 2024 | clinicaltrials |
| NCT06200233 | Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor | not yet recruiting | Phase 2 | 40 | Samsung Medical CenterOTHER | 1 | Apr 9, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Aug 6, 2026source: clinicaltrials